Udayan Guha - Feb 1, 2025 Form 3 Insider Report for NextCure, Inc. (NXTC)

Role
Chief Medical Officer
Signature
/s/ Steven P. Cobourn, as attorney-in-fact for Udayan Guha
Stock symbol
NXTC
Transactions as of
Feb 1, 2025
Transactions value $
$0
Form type
3
Date filed
2/6/2025, 04:16 PM
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NXTC Employee Stock Option (Right to Buy) Feb 1, 2025 Common Stock 65K $1.51 Direct F1
holding NXTC Employee Stock Option (Right to Buy) Feb 1, 2025 Common Stock 66.1K $1.22 Direct F2
holding NXTC Employee Stock Option (Right to Buy) Feb 1, 2025 Common Stock 52.9K $2.23 Direct F3
holding NXTC Employee Stock Option (Right to Buy) Feb 1, 2025 Common Stock 117K $0.80 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One fourth of the option vested on April 28, 2024. The remainder vests in 36 monthly installments beginning on May 31, 2024.
F2 One fourth of the option vested on January 31, 2025. The remainder vests in 36 monthly installments beginning on February 28, 2025.
F3 The option vests in full on March 29, 2025.
F4 One fourth of the option vests on January 31, 2026. The remainder vests in 36 monthly installments beginning on February 28, 2026.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney